Published in Clin Exp Immunol on August 01, 1986
CD8+/DR+ T gamma cells inhibit the autologous mixed lymphocyte reaction. Clin Exp Immunol (1990) 0.75
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
"Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A (1978) 17.69
The differentiation and function of human T lymphocytes. Cell (1980) 11.88
A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol (1976) 9.11
Regulation of cellular and humoral immune responses by T-cell subclasses. Cold Spring Harb Symp Quant Biol (1977) 5.21
Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80
A single major pathway of T-lymphocyte interactions in antigen-specific immune suppression. Scand J Immunol (1981) 3.85
Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. J Immunol (1981) 3.69
Single step separation of human T and B cells using AET treated srbc rosettes. J Immunol Methods (1976) 3.41
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction. J Exp Med (1977) 3.06
Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1978) 2.94
Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation. J Immunol (1980) 2.93
Immunoregulatory T-cell pathways. Annu Rev Immunol (1983) 2.06
Production of autoreactive I region-restricted T cell hybridomas. J Exp Med (1982) 1.70
The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J Clin Invest (1979) 1.67
A human suppressor T cell clone which recognizes an autologous helper T cell clone. Nature (1982) 1.54
Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome. J Clin Invest (1980) 1.52
Delineation of an immunoregulatory amplifier population recognizing autologous Ia molecules. Analysis with human T cell clones. J Exp Med (1984) 1.49
Human autologous mixed lymphocyte reactivity is primarily specific for xenoprotein determinants adsorbed to antigen-presenting cells during rosette formation with sheep erythrocytes. J Exp Med (1982) 1.37
The human autologous mixed lymphocyte reaction. III. Immune circuits. J Immunol (1982) 1.27
Helper factors derived from autologous mixed lymphocyte cultures. Cell Immunol (1980) 1.26
Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J Clin Invest (1980) 1.19
Communicative interactions between subpopulations of human T lymphocytes required for generation of suppressor effector function in a primary antibody response. J Immunol (1982) 1.18
Induction of immunoglobulin secreting cells in the human autologous mixed leukocyte reaction: regulation by helper and suppressor lymphocyte subsets defined with monoclonal antibodies. J Immunol (1981) 1.17
The syngeneic mixed leukocyte reaction represents polyclonal activation of antigen-specific T lymphocytes with receptors for self-Ia antigens. J Immunol (1981) 1.07
Immunoglobulin secretion in the human autologous mixed leukocyte reaction. Definition of a suppressor-amplifier circuit using monoclonal antibodies. J Exp Med (1982) 0.98
T cell regulation of B cell activation: antigen-specific and antigen-nonspecific suppressor pathways are mediated by distinct T cell subpopulations. J Immunol (1983) 0.93
Feedback suppression: an immunoregulatory circuit. Fed Proc (1980) 0.90
Fetal calf serum augmentation during cell separation procedures accounts for the majority of human autologous mixed leukocyte reactivity. Behring Inst Mitt (1983) 0.89
The regulation of antibody secreting cells generated in the autologous mixed leukocyte reaction in man. Behring Inst Mitt (1983) 0.82
T cells, T cell subsets and immunoregulation. Aust N Z J Med (1984) 0.77
Over-exposed film as a protector against solar retinopathies. Lancet (1982) 0.77
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell (1987) 9.29
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature (1986) 8.36
Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J Exp Med (1994) 5.60
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science (1986) 5.58
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med (1996) 4.15
Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. J Immunol (1981) 3.69
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sci U S A (1981) 3.63
Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man. J Exp Med (1981) 2.93
Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science (2000) 2.71
Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant (2012) 2.46
Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J Biol Chem (1990) 2.35
Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. J Immunol (1982) 2.29
Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8. J Immunol (1985) 2.22
Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques (1990) 2.22
Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens. J Immunol (1985) 2.20
Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol (1989) 2.13
Dendritic cells in cancer immunotherapy. Annu Rev Immunol (2000) 2.11
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A (2001) 1.85
Monoclonal antibody (B27M2) subdividing HLA-B27. Hum Immunol (1982) 1.81
Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer. J Immunol (1997) 1.80
Functional and quantitative alterations in T lymphocyte subpopulations in acute toxoplasmosis. J Infect Dis (1984) 1.73
Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. J Immunol (1983) 1.73
Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest (1990) 1.72
Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med (1981) 1.69
Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus. J Biol Chem (1989) 1.66
Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance. Am J Transplant (2014) 1.63
CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J Immunol (1998) 1.52
A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression. J Exp Med (1978) 1.49
Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy. J Immunol (2001) 1.46
Heterogeneous distribution and transmembrane signaling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets. J Immunol (1989) 1.46
Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clin Immunol (1999) 1.45
Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease. Arthritis Rheum (1981) 1.41
Production of functional human T-T hybridomas in selection medium lacking aminopterin and thymidine. Proc Natl Acad Sci U S A (1982) 1.41
Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study. Blood (1999) 1.40
Silicone breast implants--where have we been and where are we now? Aust N Z J Med (1996) 1.39
Discrimination of viable and non-viable cells using propidium iodide in two color immunofluorescence. Cytometry (1987) 1.32
Immunoregulatory T cell circuits in man. Alloantigen-primed inducer T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigenic stimulus. J Exp Med (1983) 1.30
Evidence for involvement of the gamma, delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones. J Immunol (1989) 1.28
Evidence for an association between CD8 molecules and the T cell receptor complex on cytotoxic T cells. J Immunol (1987) 1.28
Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using multiparameter analysis and flow cytometry. Immunol Rev (1983) 1.27
CD4 molecules are associated with the antigen receptor complex on activated but not resting T cells. J Immunol (1988) 1.26
Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue diseases, and chronic inflammatory syndromes. Ann Rheum Dis (1988) 1.26
Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS. Lancet (1984) 1.22
Human T lymphocyte proliferation induced by a pan-T monoclonal antibody (anti-Leu 4): heterogeneity of response is a function of monocytes. J Immunol (1983) 1.21
Generation of antigen-specific CD8+ CTLs from naive precursors. J Immunol (1994) 1.20
Differentiation of myeloid dendritic cells into CD8alpha-positive dendritic cells in vivo. Blood (2000) 1.20
Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J Clin Invest (1980) 1.19
Dendritic cells injected via different routes induce immunity in cancer patients. J Immunol (2001) 1.19
Induction of immunoglobulin secreting cells in the human autologous mixed leukocyte reaction: regulation by helper and suppressor lymphocyte subsets defined with monoclonal antibodies. J Immunol (1981) 1.17
Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus. J Clin Invest (1990) 1.17
Attitudes toward women physicians. A study of 500 clinic patients. West J Med (1974) 1.17
Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol (1991) 1.17
Reduced CD4+ T cells and candidiasis in absence of HIV infection. Lancet (1989) 1.16
Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation. Am J Transplant (2015) 1.15
Is C-reactive protein really useful in preterm premature rupture of the membranes? Br J Obstet Gynaecol (1987) 1.15
Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells. J Clin Invest (1987) 1.14
Blocking of human T lymphocyte functions by anti-Leu-2 and anti-Leu-3 antibodies: differential inhibition of proliferation and suppression. J Immunol (1983) 1.11
Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones. J Immunol (1990) 1.11
Cascade control of E. coli glutamine synthetase. II. Metabolite regulation of the enzymes in the cascade. Arch Biochem Biophys (1978) 1.11
Natural killer lines and clones with apparent antigen specificity. J Exp Med (1990) 1.10
Utility of formaldehyde fixation for flow cytometry and inactivation of the AIDS associated retrovirus. J Immunol Methods (1986) 1.10
Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation (2000) 1.09
Immune regulation: a critical link between NK cells and CTLs. Immunol Today (1996) 1.08
Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. J Immunol (1997) 1.08
An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum (1994) 1.08
Post-mammoplasty connective tissue disease. Arthritis Rheum (1982) 1.08
Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol (1986) 1.08
Degradation of CD4 following phorbol-induced internalization in human T lymphocytes. Evidence for distinct endocytic routing of CD4 and CD3. J Biol Chem (1992) 1.05
Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochem Pharmacol (1986) 1.04
Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae. Infect Immun (1990) 1.04
Early activation events render T cells susceptible to HIV-1-induced syncytia formation. Role of protein kinase C. J Biol Chem (1991) 1.04
Cultured human epidermal cells do not synthesize HLA-DR. J Invest Dermatol (1982) 1.02
Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (1990) 1.02
Mixed lymphocyte reaction in healthy women with rheumatoid factor. Lack of association with HLA-Dw4. Arthritis Rheum (1979) 1.02
Induction of immunoglobulin-secreting cells in the allogeneic mixed leukocyte reaction: regulation by helper and suppressor lymphocyte subsets in man. J Immunol (1981) 1.02
Expression and processing of human immunodeficiency virus type 1 gag and pol genes by cells infected with a recombinant vaccinia virus. J Virol (1989) 1.02
Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity. J Immunol (1989) 1.02
A human alloreactive inducer T cell clone that selectively activates antigen-specific suppressor T cells. J Immunol (1984) 1.02
Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method. Hum Immunol (1983) 1.02
Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines. J Immunol (1988) 1.02
Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation. J Biol Chem (1991) 1.02
Immunoregulatory T cell circuits in man. Identification of a distinct T cell subpopulation of the helper/inducer lineage that amplifies the development of alloantigen-specific suppressor T cells. J Immunol (1985) 1.01
Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell Immunol (1996) 1.01
Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells. Immunology (1995) 1.00
Activation of antigen-specific suppressor T cells in the presence of cyclosporin requires interactions between T cells of inducer and suppressor lineage. J Clin Invest (1983) 1.00
Maturational and functional diversity of human B lymphocytes delineated with anti-Leu-8. J Immunol (1985) 1.00
Variable gene usage of T cell receptor gamma- and delta-chain transcripts expressed in synovia and peripheral blood of patients with rheumatoid arthritis. Clin Exp Immunol (1992) 1.00
A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man. J Clin Invest (1978) 1.00
Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells. J Exp Med (1980) 0.98
Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma. J Immunol Methods (1984) 0.98
Immunoglobulin secretion in the human autologous mixed leukocyte reaction. Definition of a suppressor-amplifier circuit using monoclonal antibodies. J Exp Med (1982) 0.98
Identification of an immunostimulating protein from Mycobacterium leprae. Infect Immun (1990) 0.98
Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. Biol Blood Marrow Transplant (2000) 0.97